Inclusion Criteria : 
  -  Subject scheduled for total pancreatectomy or pancreaticoduodenectomy
  -  Informed consent signed prior to any study - related procedure
Exclusion Criteria : 
  -  Known liver disease before total pancreatectomy or pancreaticoduodenectomy ( excluding NAFLD ) 
  -  Severe co - morbid disease ( besides from the indication for the pancreas surgery ) 
  -  Pregnancy
  -  Any condition that the investigator feels would interfere with the safety of the trial participation or the safety of the subject
  -  Metastatic disease
Percutaneous liver biopsy exclusion criteria ( to be evaluated before last visit ) 
  -  MR spectroscopy demonstrating lipid content < 2 % 
  -  Haemoglobin < 6 mmol / L
  -  INR > 1.5 
  -  Trombocytes < 40 Ã— 109 / L
  -  Skin infection in area where biopsy will be sampled